These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36694705)

  • 1. Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization.
    Mohammadi S; Aghabozorg F; Balagholi S; Ferdowsi S; Sharifi S; Eshghi P
    Int J Hematol Oncol Stem Cell Res; 2022 Jul; 16(3):151-156. PubMed ID: 36694705
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.
    Cheraghali AM; Abolghasemi H
    Haemophilia; 2009 Mar; 15(2):487-93. PubMed ID: 19347989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].
    Ritter S; Hamouda O; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):914-22. PubMed ID: 22842884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial.
    Haugen M; Magnussen K; Aarsland TE; Nissen-Meyer LSH; Strand TA
    Trials; 2024 Mar; 25(1):175. PubMed ID: 38468338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the plasmapheresis donor in a voluntary, nonremunerated environment.
    Bove LL; Bednall T; Masser B; Buzza M
    Transfusion; 2011 Nov; 51(11):2411-24. PubMed ID: 21564104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of blood transfusion system of iran: 2002-2011.
    Cheraghali A
    Iran J Public Health; 2012; 41(8):89-93. PubMed ID: 23113231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building a flexible, voluntary donation panel: an exploration of donor willingness.
    Bagot KL; Masser BM; Starfelt LC; White KM
    Transfusion; 2016 Jan; 56(1):186-94. PubMed ID: 26408074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative experiences and donor return: an examination of the role of asking for something different.
    Masser BM; Bove LL; White KM; Bagot KL
    Transfusion; 2016 Mar; 56(3):605-13. PubMed ID: 26472686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment.
    Bagot KL; Bove LL; Masser BM; Bednall TC; Buzza M
    Transfusion; 2013 May; 53(5):1108-19. PubMed ID: 22998759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four decades of National Blood Service in Iran: outreach, prospect and challenges.
    Pourfathollah AA; Hosseini Divkolaye NS; Seighali F
    Transfus Med; 2015 Jun; 25(3):138-43. PubMed ID: 26040645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asking for something different from our donors: factors influencing persuasion success.
    Bagot KL; Bove LL; Masser BM; White KM
    Transfusion; 2014 Mar; 54(3 Pt 2):848-55. PubMed ID: 24274901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Plasma Unit Weight and Donor Sex on Post-Donation Citrate Level: An Experimental Study on Plasmapheresis Donors.
    Marraccini C; Schiroli D; Mancuso P; Molinari G; Razzoli A; Gavioli G; Fasano T; Baricchi R; Rossi PG; Merolle L
    Transfus Med Hemother; 2023 Dec; 50(6):491-501. PubMed ID: 38089491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gone, but haven't forgotten: insights on plasmapheresis donation from lapsed donors.
    Thorpe R; Nguyen L; Masser BM; Van Dyke N; Davison TE
    Vox Sang; 2021 Mar; 116(3):281-287. PubMed ID: 32966699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demography and donation frequencies of blood and plasma donor populations in Germany].
    Ritter S; Willand L; Reinhard B; Offergeld R; Hamouda O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Aug; 51(8):915-25. PubMed ID: 18787870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A successful experience of the Iranian blood transfusion organization in improving accessibility and affordability of plasma derived medicine.
    Chegini A; Torab SA; Pourfatollah AA
    Transfus Apher Sci; 2017 Feb; 56(1):12-16. PubMed ID: 28214180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.